CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts

Summary The malarial parasite has two hosts in its life cycle, a vertebrate and a mosquito. We report here that malarial invasion into these hosts is mediated by a protein, designated cell‐traversal protein for ookinetes and sporozoites (CelTOS), which is localized to micronemes that are organelles...

Full description

Saved in:
Bibliographic Details
Published inMolecular microbiology Vol. 59; no. 5; pp. 1369 - 1379
Main Authors Kariu, Tohru, Ishino, Tomoko, Yano, Kazuhiko, Chinzei, Yasuo, Yuda, Masao
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary The malarial parasite has two hosts in its life cycle, a vertebrate and a mosquito. We report here that malarial invasion into these hosts is mediated by a protein, designated cell‐traversal protein for ookinetes and sporozoites (CelTOS), which is localized to micronemes that are organelles for parasite invasive motility. Targeted disruption of the CelTOS gene in Plasmodium berghei reduced parasite infectivity in the mosquito host approximately 200‐fold. The disruption also reduced the sporozoite infectivity in the liver and almost abolished its cell‐passage ability. Liver infectivity was restored in Kupffer cell‐depleted rats, indicating that CelTOS is necessary for sporozoite passage from the circulatory system to hepatocytes through the liver sinusoidal cell layer. Electron microscopic analysis revealed that celtos‐disrupted ookinetes invade the midgut epithelial cell by rupturing the cell membrane, but then fail to cross the cell, indicating that CelTOS is necessary for migration through the cytoplasm. These results suggest that conserved cell‐passage mechanisms are used by both sporozoites and ookinetes to breach host cellular barriers. Elucidation of these mechanisms might lead to novel antimalarial strategies to block parasite's transmission.
Bibliography:
These authors contributed equally to this work.
Sojo University, School of Pharmacological Sciences, 4‐22‐1 Ikeda, Kumamoto‐shi, Kumamoto 860‐0082, Japan.
§
Present addresses
Research Institute, International Medical Center of Japan, 1‐21‐1 Toyama, Shinjuku‐ku, Tokyo 162‐8655, Japan.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-382X
1365-2958
DOI:10.1111/j.1365-2958.2005.05024.x